文献速递慢性肾脏病血液净化与透析

COVID-19 疫情期间老年肾脏病患者的治疗决策制定

Treatment Decision Making for Older Kidney Patients during COVID-19.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-06-07

该研究对2020年8月至12月来自波士顿、波特兰(缅因州)、圣迭戈和芝加哥的76名参与者(39例CKD 4-5期且年龄70岁以上的患者、17名照护伙伴和20名临床医生)进行半结构化访谈的主题和叙事分析,探讨COVID-19疫情如何影响老年晚期CKD患者的肾脏治疗决策。研究发现四个主题:适应变化的患者教育实践、重新认识脆弱性、接受居家透析但不接受保守管理、以及不确定条件下对治疗决策的满意度和安全感。结论指出临床医生更倾向于鼓励居家透析模式,但对脆弱性、预先护理计划和保守管理的讨论仍然有限。

要点

  • 临床医生在疫情期间更易鼓励老年CKD患者采用居家透析模式。
  • 关于脆弱性、预先护理计划和保守管理的讨论仍然有限。
  • 临床医生报告因疫情导致职业倦怠、时间需求增加和人力限制。

核心结论

  • 临床医生在COVID-19疫情期间感知到老年CKD患者更大的脆弱性并更易鼓励居家透析模式,但对脆弱性、预先护理计划和保守管理的讨论仍然有限,提示存在改进空间。
  • 临床医生报告疫情导致职业倦怠、时间需求增加和人力限制,而患者尽管面临不确定性仍对治疗选择保持满意。

研究设计与样本

  • 对2020年8月至12月来自波士顿、波特兰(缅因州)、圣迭戈和芝加哥的CKD 4期和5期且年龄70岁以上的患者、照护伙伴和临床医生进行半结构化访谈,采用主题和叙事分析。
  • 共访谈76名参与者:39例患者、17名照护伙伴和20名临床医生。
  • 患者参与者中13例(33%)自我认同为黑人,7例(18%)已开始透析。
  • 临床试验注册:Decision Aid for Renal Therapy (DART), NCT03522740。

主要发现

  • 共呈现四个主题及相应子主题:(1)适应变化的教育和患者参与实践(患者照护障碍和远程医疗的新机会);(2)重新认识脆弱性(临床医生对疾病严重性的认识增加,但对患者COVID-19脆弱性的讨论有限);(3)接受居家透析但不接受保守管理(对居家模式的开放态度,但对保守管理和预先护理计划的讨论有限);(4)尽管处于不确定条件,对治疗决策仍感到满意和安全。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Coronavirus disease 2019 (COVID-19) disrupted medical care across health care settings for older patients with advanced CKD. Understanding how shared decision making for kidney treatment decisions was influenced by the uncertainty of an evolving pandemic can provide insights for supporting shared decision making through the current and future public health crises. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed thematic and narrative analyses of semistructured interviews with patients (CKD stages 4 and 5, age 70+), care partners, and clinicians from Boston, Portland (Maine), San Diego, and Chicago from August to December 2020. RESULTS: We interviewed 76 participants (39 patients, 17 care partners, and 20 clinicians). Among patient participants, 13 (33%) patients identified as Black, and seven (18%) had initiated dialysis. Four themes with corresponding subthemes emerged related to treatment decision making and the COVID-19 pandemic: (1) adapting to changed educational and patient engagement practices (patient barriers to care and new opportunities for telemedicine); (2) reconceptualizing vulnerability (clinician awareness of illness severity increased and limited discussions of patient COVID-19 vulnerability); (3) embracing home-based dialysis but not conservative management (openness to home-based modalities and limited discussion of conservative management and advanced care planning); and (4) satisfaction and safety with treatment decisions despite conditions of uncertainty. CONCLUSIONS: Although clinicians perceived greater vulnerability among older patients CKD and more readily encouraged home-based modalities during the COVID-19 pandemic, their discussions of vulnerability, advance care planning, and conservative management remained limited, suggesting areas for improvement. Clinicians reported burnout caused by the pandemic, increased time demands, and workforce limitations, whereas patients remained satisfied with their treatment choices despite uncertainty. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Decision Aid for Renal Therapy (DART), NCT03522740.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Porteny T, Gonzales KM, Aufort KE, et al. Treatment Decision Making for Older Kidney Patients during COVID-19. Clin J Am Soc Nephrol. 2022. PMID: 35672037. doi:10.2215/CJN.13241021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。